Antibody responses of calves to Histophilus somni recombinant IbpA subunits

Kimberly L. Lo, Richard A. Kimball, Jason Lehmann, Laurel J Gershwin, Carolyn Worby, Lynette B. Corbeil

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Histophilus somni causes bovine pneumonia and septicemia, but protective immune responses are not well understood and immunodiagnostic methods are not well defined. We previously showed that antibody to a new virulence factor, IbpA, neutralizes cytotoxicity and immunization with a recombinant IbpA domain protects calves against experimental . H. somni pneumonia. To further define immune responses to IbpA, we determined isotypic serum antibody responses to three IbpA domains (IbpA3, an N-terminal coiled coil region; IbpA5, a central region of 200. bp repeats and IbpA DR2, a C-terminal cytotoxic domain). ELISA was used to quantitate IgG1 or IgG2 antibodies to each of the IbpA subunits as well as . H. somni whole cells (WCs) or culture supernatant (SUP). Calves experimentally infected with . H. somni and monitored for up to 10 weeks had the least " 0 time" (background) antibody levels to IbpA5, as well as the earliest and highest responses of greatest duration to the IbpA5 subunit. Responses of these calves were high to WC or SUP antigens but with higher " 0 time" (background) antibody levels. We concluded that IbpA5 may be a useful immunodiagnostic antigen. Calves immunized with . H. somni WC vaccine had antibody responses to WC antigens, but not to IbpA subunits before challenge. After challenge with . H. somni, vaccinated calves had slight anamnestic responses to IbpA3 and IbpA5, but not to IbpA DR2. Since IbpA DR2 is a protective antigen, the data suggest the IbpA DR2 would be a useful addition to . H. somni vaccines.

Original languageEnglish (US)
Pages (from-to)453-459
Number of pages7
JournalComparative Immunology, Microbiology and Infectious Diseases
Volume35
Issue number5
DOIs
StatePublished - Sep 2012

Fingerprint

Pasteurellaceae
Antibody Formation
calves
Antigens
antibodies
Antibodies
antigens
Pneumonia
Vaccines
Immunoglobulin G
pneumonia
Virulence Factors
immune response
cells
vaccines
Immunization
Sepsis
Cell Culture Techniques
Enzyme-Linked Immunosorbent Assay
septicemia

Keywords

  • Fic
  • H. somni vaccines
  • Histophilus somni
  • IbpA antibodies
  • Immunoglobulin binding protein A

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Infectious Diseases
  • Immunology and Allergy
  • veterinary(all)

Cite this

Antibody responses of calves to Histophilus somni recombinant IbpA subunits. / Lo, Kimberly L.; Kimball, Richard A.; Lehmann, Jason; Gershwin, Laurel J; Worby, Carolyn; Corbeil, Lynette B.

In: Comparative Immunology, Microbiology and Infectious Diseases, Vol. 35, No. 5, 09.2012, p. 453-459.

Research output: Contribution to journalArticle

Lo, Kimberly L. ; Kimball, Richard A. ; Lehmann, Jason ; Gershwin, Laurel J ; Worby, Carolyn ; Corbeil, Lynette B. / Antibody responses of calves to Histophilus somni recombinant IbpA subunits. In: Comparative Immunology, Microbiology and Infectious Diseases. 2012 ; Vol. 35, No. 5. pp. 453-459.
@article{9fbccd4a0da943b68eb0a52cfbe36ace,
title = "Antibody responses of calves to Histophilus somni recombinant IbpA subunits",
abstract = "Histophilus somni causes bovine pneumonia and septicemia, but protective immune responses are not well understood and immunodiagnostic methods are not well defined. We previously showed that antibody to a new virulence factor, IbpA, neutralizes cytotoxicity and immunization with a recombinant IbpA domain protects calves against experimental . H. somni pneumonia. To further define immune responses to IbpA, we determined isotypic serum antibody responses to three IbpA domains (IbpA3, an N-terminal coiled coil region; IbpA5, a central region of 200. bp repeats and IbpA DR2, a C-terminal cytotoxic domain). ELISA was used to quantitate IgG1 or IgG2 antibodies to each of the IbpA subunits as well as . H. somni whole cells (WCs) or culture supernatant (SUP). Calves experimentally infected with . H. somni and monitored for up to 10 weeks had the least {"} 0 time{"} (background) antibody levels to IbpA5, as well as the earliest and highest responses of greatest duration to the IbpA5 subunit. Responses of these calves were high to WC or SUP antigens but with higher {"} 0 time{"} (background) antibody levels. We concluded that IbpA5 may be a useful immunodiagnostic antigen. Calves immunized with . H. somni WC vaccine had antibody responses to WC antigens, but not to IbpA subunits before challenge. After challenge with . H. somni, vaccinated calves had slight anamnestic responses to IbpA3 and IbpA5, but not to IbpA DR2. Since IbpA DR2 is a protective antigen, the data suggest the IbpA DR2 would be a useful addition to . H. somni vaccines.",
keywords = "Fic, H. somni vaccines, Histophilus somni, IbpA antibodies, Immunoglobulin binding protein A",
author = "Lo, {Kimberly L.} and Kimball, {Richard A.} and Jason Lehmann and Gershwin, {Laurel J} and Carolyn Worby and Corbeil, {Lynette B.}",
year = "2012",
month = "9",
doi = "10.1016/j.cimid.2012.04.002",
language = "English (US)",
volume = "35",
pages = "453--459",
journal = "Comparative Immunology, Microbiology and Infectious Diseases",
issn = "0147-9571",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Antibody responses of calves to Histophilus somni recombinant IbpA subunits

AU - Lo, Kimberly L.

AU - Kimball, Richard A.

AU - Lehmann, Jason

AU - Gershwin, Laurel J

AU - Worby, Carolyn

AU - Corbeil, Lynette B.

PY - 2012/9

Y1 - 2012/9

N2 - Histophilus somni causes bovine pneumonia and septicemia, but protective immune responses are not well understood and immunodiagnostic methods are not well defined. We previously showed that antibody to a new virulence factor, IbpA, neutralizes cytotoxicity and immunization with a recombinant IbpA domain protects calves against experimental . H. somni pneumonia. To further define immune responses to IbpA, we determined isotypic serum antibody responses to three IbpA domains (IbpA3, an N-terminal coiled coil region; IbpA5, a central region of 200. bp repeats and IbpA DR2, a C-terminal cytotoxic domain). ELISA was used to quantitate IgG1 or IgG2 antibodies to each of the IbpA subunits as well as . H. somni whole cells (WCs) or culture supernatant (SUP). Calves experimentally infected with . H. somni and monitored for up to 10 weeks had the least " 0 time" (background) antibody levels to IbpA5, as well as the earliest and highest responses of greatest duration to the IbpA5 subunit. Responses of these calves were high to WC or SUP antigens but with higher " 0 time" (background) antibody levels. We concluded that IbpA5 may be a useful immunodiagnostic antigen. Calves immunized with . H. somni WC vaccine had antibody responses to WC antigens, but not to IbpA subunits before challenge. After challenge with . H. somni, vaccinated calves had slight anamnestic responses to IbpA3 and IbpA5, but not to IbpA DR2. Since IbpA DR2 is a protective antigen, the data suggest the IbpA DR2 would be a useful addition to . H. somni vaccines.

AB - Histophilus somni causes bovine pneumonia and septicemia, but protective immune responses are not well understood and immunodiagnostic methods are not well defined. We previously showed that antibody to a new virulence factor, IbpA, neutralizes cytotoxicity and immunization with a recombinant IbpA domain protects calves against experimental . H. somni pneumonia. To further define immune responses to IbpA, we determined isotypic serum antibody responses to three IbpA domains (IbpA3, an N-terminal coiled coil region; IbpA5, a central region of 200. bp repeats and IbpA DR2, a C-terminal cytotoxic domain). ELISA was used to quantitate IgG1 or IgG2 antibodies to each of the IbpA subunits as well as . H. somni whole cells (WCs) or culture supernatant (SUP). Calves experimentally infected with . H. somni and monitored for up to 10 weeks had the least " 0 time" (background) antibody levels to IbpA5, as well as the earliest and highest responses of greatest duration to the IbpA5 subunit. Responses of these calves were high to WC or SUP antigens but with higher " 0 time" (background) antibody levels. We concluded that IbpA5 may be a useful immunodiagnostic antigen. Calves immunized with . H. somni WC vaccine had antibody responses to WC antigens, but not to IbpA subunits before challenge. After challenge with . H. somni, vaccinated calves had slight anamnestic responses to IbpA3 and IbpA5, but not to IbpA DR2. Since IbpA DR2 is a protective antigen, the data suggest the IbpA DR2 would be a useful addition to . H. somni vaccines.

KW - Fic

KW - H. somni vaccines

KW - Histophilus somni

KW - IbpA antibodies

KW - Immunoglobulin binding protein A

UR - http://www.scopus.com/inward/record.url?scp=84864121674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864121674&partnerID=8YFLogxK

U2 - 10.1016/j.cimid.2012.04.002

DO - 10.1016/j.cimid.2012.04.002

M3 - Article

C2 - 22554920

AN - SCOPUS:84864121674

VL - 35

SP - 453

EP - 459

JO - Comparative Immunology, Microbiology and Infectious Diseases

JF - Comparative Immunology, Microbiology and Infectious Diseases

SN - 0147-9571

IS - 5

ER -